Skip to main content

Sheri L. Holmen, Ph.D.

Languages spoken: English

Academic Information

Departments: Surgery - Professor, Oncological Sciences - Adjunct Professor

Divisions: General Surgery

Academic Office Information

Sheri.Holmen@hci.utah.edu

Labs

Research Interests

  • Glioma
  • Melanoma
  • Mouse Models of Cancer
  • Virology
  • Oncogenes
  • Genes, Tumor Suppressor

Sheri Holmen, PhD, is a Huntsman Cancer Institute (HCI) investigator and Co-Director of the Melanoma Disease Oriented Research Team (MDOT). She is a Professor in the Department of Surgery at the University of Utah School of Medicine, as well as an Adjunct Professor in the Department of Oncological Sciences.

Dr. Holmen’s Lab aims to define critical targets in cancer cells that can become the focus for therapeutic intervention. Current efforts utilize a genetic approach to address this question in tumors that are generally refractory to conventional therapies, including metastatic melanoma and glioblastoma. Identified targets are being further validated using pharmacological inhibitors of clinical importance such that laboratory findings can be quickly translated to the clinic.

Dr. Holmen earned her bachelor's and master’s degrees from Western Michigan University followed by a PhD degree from the Mayo Clinic College of Medicine. Her postdoctoral research was performed in the Laboratory of Cell Signaling and Carcinogenesis at the Van Andel Research Institute.

Education History

Postdoctoral Fellowship Van Andel Research Institute
Postdoctoral Fellow
Doctoral Training Mayo Clinic College of Medicine
Biomedical Science, Tumor Biology
PhD
Graduate Training Western Michigan University
Biomedical Science
MS
Undergraduate Western Michigan University
Biomedical Science
BS